Dr. Vinay Prasad (Source: FDA) The Food and Drug Administration (FDA) has confirmed that Dr. Vinay Prasad is leaving the agency for the second time in less than a year. Prasad, director of the FDA’s Center for Biologics Evaluation and Research (CBER), will depart at the end of April, with no successor named yet. Prasad was appointed in 2025 to lead the FDA’s Center for Biologics Evaluation and Research (CBER), the division responsible for regulating vaccines, blood products, and gene therapies. Prasad’s first departure came in July 2025, when he abruptly resigned after only a few months in the role following an explosive exposé led by investigative journalist Laura Loomer. The Gateway Pundit reported last year that Loomer publicly exposed Prasad’s shocking anti-Trump rhetoric, far-left…
Click here to read the full article at The Gateway Pundit.
